Loading...
Brazil has emerged as India's second-largest pharmaceutical export destination, overtaking several traditional European markets as Indian drugmakers strengthen their presence in Latin America's largest healthcare market. Exports to Brazil reached $916 million and are on track to cross the $1 billion mark in FY27 if the current growth momentum continues.
According to trade data from the Directorate General of Commercial Intelligence and Statistics (DGCIS), Brazil now accounts for 2.94% of India's pharmaceutical exports, behind only the United States, which continues to dominate with a market share of more than 30%. Indian pharmaceutical shipments to Brazil have recorded a compound annual growth rate of 17-18% over the past two years.
The growing demand is being driven by Brazil's expanding pharmaceutical market, valued at around $45 billion in 2024. Rising healthcare expenditure, strong demand for generic medicines and increased government procurement have created opportunities for Indian manufacturers known for supplying affordable, high-quality drugs.
Despite the strong growth, Brazil remains one of the more challenging export markets for pharmaceutical companies. The country's drug regulator, ANVISA, maintains stringent approval and manufacturing compliance standards that are often considered comparable to those of leading global regulators. Industry executives also point to currency volatility and complex registration procedures as key challenges for exporters.
Indian pharmaceutical companies have expanded their footprint by participating in government tenders and strengthening partnerships with local distributors and retail pharmacy networks. Industry experts say ongoing engagement between India's Pharmaceuticals Export Promotion Council (Pharmexcil) and Brazilian regulatory authorities has helped companies better navigate the country's regulatory framework and market-entry requirements.
Several Indian drugmakers, including Torrent Pharmaceuticals, have established a strong presence in Brazil across therapeutic segments such as central nervous system and cardiovascular medicines. Other leading manufacturers are also increasing investments to expand product portfolios and strengthen distribution networks in the country.
The rapid growth in exports highlights India's increasing diversification beyond its traditional pharmaceutical markets. With sustained demand for generic medicines and continued regulatory engagement, Brazil is expected to remain a key growth driver for India's pharmaceutical exports in the coming years.
Follow CARGOCONNECT for more such updates.
Brazil has emerged as India's second-largest pharmaceutical export destination, overtaking several traditional European markets as Indian drugmakers strengthen their presence in Latin America's largest healthcare market. Exports to Brazil reached $916 million and are on track to cross the $1 billion mark in FY27 if the current growth momentum continues. According to trade data from the Directorate General of Commercial Intelligence and Statistics (DGCIS), Brazil now accounts for 2.94% of India's pharmaceutical exports, behind only the United States, which continues to dominate with a market share of more than 30%. Indian pharmaceutical shipments to Brazil have recorded a compound annual growth rate of 17-18% over the past two years. The growing demand is being driven by Brazil's expanding pharmaceutical market, valued at around $45 billion in 2024. Rising healthcare expenditure, strong demand for generic medicines and increased government procurement have created opportunities for Indian manufacturers known for supplying affordable, high-quality drugs. Despite the strong growth, Brazil remains one of the more challenging export markets for pharmaceutical companies. The country's drug regulator, ANVISA, maintains stringent approval and manufacturing compliance standards that are often considered comparable to those of leading global regulators. Industry executives also point to currency volatility and complex registration procedures as key challenges for exporters. Indian pharmaceutical companies have expanded their footprint by participating in government tenders and strengthening partnerships with local distributors and retail pharmacy networks. Industry experts say ongoing engagement between India's Pharmaceuticals Export Promotion Council (Pharmexcil) and Brazilian regulatory authorities has helped companies better navigate the country's regulatory framework and market-entry requirements. Several Indian drugmakers, including Torrent Pharmaceuticals, have established a strong presence in Brazil across therapeutic segments such as central nervous system and cardiovascular medicines. Other leading manufacturers are also increasing investments to expand product portfolios and strengthen distribution networks in the country. The rapid growth in exports highlights India's increasing diversification beyond its traditional pharmaceutical markets. With sustained demand for generic medicines and continued regulatory engagement, Brazil is expected to remain a key growth driver for India's pharmaceutical exports in the coming years. Follow CARGOCONNECT for more such updates.
India has joined a US-led initiative aimed at building secure and resilient supply chains for artificial intelligence (AI), semiconductors and other critical technologies, becoming one of 35 participating countries in the Pax Silica partnership. The move is expected to deepen international cooperation on trusted technology ecosystems while reducing vulnerabilities in global AI supply chains. The announcement was made at the Pax Silica Summit, where participating countries endorsed a joint declaration promoting collaboration across AI infrastructure, semiconductor manufacturing, advanced computing, critical minerals, energy systems and digital connectivity. The initiative is designed to strengthen supply chain resilience by encouraging trusted partnerships among member nations. For India, participation is expected to support ongoing efforts to expand domestic semiconductor manufacturing, strengthen electronics production and attract investment into AI infrastructure. The partnership also aligns with the country's broader objective of becoming a key node in global technology and manufacturing supply chains. Beyond semiconductors, the initiative covers the full AI value chain, including software platforms, data infrastructure, advanced manufacturing, logistics networks, mineral processing and energy systems required to support next-generation computing. Member countries have committed to improving coordination on investment, infrastructure development and supply chain security. The expanded coalition reflects growing international efforts to diversify technology supply chains amid increasing geopolitical competition and concerns over concentrated manufacturing capacities. By strengthening cooperation among trusted partners, Pax Silica seeks to improve the reliability of supplies for industries dependent on AI, high-performance computing and advanced electronics. Industry observers say India's inclusion could enhance its role in the global semiconductor and AI ecosystem by creating new opportunities for investment, technology collaboration and supply chain integration. As demand for AI infrastructure continues to grow, participation in multilateral technology partnerships is expected to play an increasingly important role in shaping future manufacturing and logistics networks. Follow CARGOCONNECT for more such updates.
India and the United States signalled a renewed effort to strengthen bilateral ties at the G7 Summit in France, with Prime Minister Narendra Modi and US President Donald Trump discussing progress on a proposed trade agreement while placing renewed emphasis on maritime security and the safety of seafarers operating in the Gulf region. The meeting, held on the sidelines of the summit, comes after months of friction over tariffs, energy trade and geopolitical issues. Despite those challenges, both leaders struck a conciliatory tone and indicated that negotiations on a bilateral trade arrangement are moving closer to conclusion. Trump described discussions as productive and suggested that a trade agreement could be finalised in the near future. For the logistics and shipping industry, maritime security emerged as one of the most significant topics of the talks. Modi highlighted the importance of maintaining safe and uninterrupted navigation through the Strait of Hormuz, a critical maritime corridor for global energy shipments and international trade. He stressed that the safety of Indian seafarers working on merchant vessels across global shipping routes must remain a priority amid ongoing instability in West Asia. The issue has gained urgency following recent incidents in the Gulf region that resulted in the deaths of Indian sailors aboard commercial vessels. India has raised concerns about the impact of regional tensions on maritime trade and crew safety, with Modi urging greater international attention to the protection of seafarers and the security of shipping lanes. The Strait of Hormuz remains one of the world's most strategically important maritime chokepoints, handling a substantial share of global oil and gas exports. Any disruption to navigation through the corridor can have immediate consequences for shipping schedules, freight costs, energy markets and supply chains worldwide. In addition to maritime issues, the two leaders reviewed progress in trade negotiations that have continued despite disagreements over tariffs and energy imports. Officials from both countries are expected to continue discussions in the coming weeks, with trade representatives working toward an interim agreement that could ease commercial tensions and support greater bilateral trade flows. The meeting marked the first face-to-face engagement between Modi and Trump in more than a year and underscored the strategic importance both governments place on maintaining cooperation across trade, energy, security and logistics. For the global shipping sector, the renewed focus on maritime safety and freedom of navigation signals continued attention to securing critical trade routes amid persistent geopolitical uncertainty in West Asia. Follow CARGOCONNECT for more such updates.
